Company Filing History:
Years Active: 1995-2017
Title: Junji Uchida: Innovator in Antitumor Research
Introduction
Junji Uchida is a prominent inventor based in Tokushima, Japan. He has made significant contributions to the field of cancer treatment through his innovative research and development of antitumor agents. With a total of 3 patents to his name, Uchida's work is recognized for its potential impact on enhancing the effectiveness of cancer therapies.
Latest Patents
Uchida's latest patents focus on an antitumor effect potentiator and antitumor agent. The invention provides a formulation that enhances the antitumor activity of an agent comprising tegafur, gimeracil, and oteracil potassium. This combination is designed to improve therapeutic outcomes while minimizing side effects. The antitumor effect potentiator also includes folinic acid and its pharmacologically acceptable salts. The methods outlined in the patents involve administering this potentiator to patients to enhance the antitumor effect and inhibit tumor growth.
Career Highlights
Junji Uchida is associated with Taiho Pharmaceutical Company Limited, where he has been instrumental in advancing cancer treatment solutions. His research has led to the development of innovative therapies that aim to improve patient outcomes in oncology.
Collaborations
Uchida has collaborated with notable colleagues, including Koyo Shudo and Tadafumi Terada, to further his research efforts. Their combined expertise has contributed to the success of their projects and the advancement of cancer treatment methodologies.
Conclusion
Junji Uchida's work in the field of antitumor research exemplifies the importance of innovation in medicine. His patents and collaborations reflect a commitment to improving cancer therapies and patient care.